Abstract
The TEMPI syndrome is a rare and acquired disorder characterized by 5 salient features, which compose its name: (1) telangiectasias; (2) elevated erythropoietin and erythrocytosis; (3) monoclonal gammopathy; (4) perinephric fluid collections; and (5) intrapulmonary shunting. Complete resolution of symptoms following treatment with plasma cell-directed therapy supports the hypothesis that the monoclonal antibody is causal and pathogenic. Understanding the basis of the TEMPI syndrome will depend on the identification of additional patients and a coordinated international effort.
Cite
CITATION STYLE
Sykes, D. B., O’Connell, C., & Schroyens, W. (2020, April 9). The TEMPI syndrome. Blood. American Society of Hematology. https://doi.org/10.1182/BLOOD.2019004216
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.